Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: Int J Cancer. 2021 Jul 14;149(7):1483–1494. doi: 10.1002/ijc.33732

Table 2.

Incidence Rate of Type-Specific Oral Human Papillomavirus (HPV) Infection, by Prior Genital HPV Infection Status in the HPV Infection in Men Study

No Prior Genital HPV Infectiona Prior Genital HPV Infectionb
HPV Type Subjects at Risk, N Incident Infections, N Person-Months Incidence per 1000 Person-Months (95% CI)a Subjects at Risk, N Incident Infections, N Person-Months Incidence per 1000 Person-Months (95% CI)a Incidence Rate Ratio (95% CI)
9vHPVb 2112 131 14293.20 9.59 (7.97, 11.53) 563 73 4076.53 18.59 (14.54, 23.78) 1.94 (1.45, 2.59)
Low Riskc 2624 29 18035.33 1.08 (0.60, 1.93) 160 7 1145.13 3.85 (1.61, 9.21) 3.56 (1.55, 8.15)
High Riskd 2260 131 15408.67 9.07 (7.55, 10.89) 444 51 3161.97 17.62 (13.22, 23.49) 1.94 (1.40, 2.69)
Type 6 2670 16 18395.70 0.71 (0.37, 1.35) 125 5 871.50 4.40 (1.67, 11.65) 6.24 (2.26, 17.17)
Type 11 2805 15 19361.03 0.44 (0.19, 1.01) 36 2 279.07 2.83 (0.57, 13.97) 6.43 (1.45, 28.38)
Type 16 2628 39 18109.27 2.26 (1.61, 3.17) 170 13 1213.90 10.59 (5.89, 19.05) 4.68 (2.48, 8.84)
Type 18 2762 15 19103.67 0.58 (0.29, 1.15) 65 5 459.37 10.19 (3.81, 27.20) 17.52 (6.24, 49.22)
Type 31 2797 17 19270.23 0.68 (0.32, 1.45) 41 2 306.43 5.49 (1.22, 24.79) 8.04 (1.84, 35.07)
Type 33 2828 9 19548.97 0.40 (0.17, 0.95) 19 0 127.87 0.00 (NE) NE
Type 45 2781 9 19181.07 0.51 (0.25, 1.03) 45 1 318.87 3.83 (0.53, 27.74) 7.50 (0.94, 59.94)
Type 52 2698 93 18530.97 4.84 (3.79, 6.19) 113 6 850.20 6.62 (2.92, 15.02) 1.37 (0.60, 3.13)
Type 58 2751 3 19026.27 0.17 (0.05, 0.57) 76 1 553.63 1.77 (0.21, 15.14) 10.41 (1.03, 105.42)
a

Adjusted for country and age groups

b

Infections due to any of the 9 vaccine-type HPVs: 6, 11, 16, 18, 31, 33, 45, 52, 58

c

Infections due to HPV 16, 18, 31, 33, 45, 52, 58

d

Infections due to HPV 6 and 11